Our insights

Current issue
Prospects
Autumn Issue Forty
The JM Finn Quarterly Periodical

In November, the final members of staff moved into our new London headquarters at 25 Copthall Avenue.

As part of our focus on providing a high quality, personalised investment service, we look to support our investment managers in their decision making when it comes to constructing client portfolios.

The COVID-19 pandemic increased the Internet’s importance amongst nearly all consumers and businesses.

Senior Investment Manager, London

At the time of writing the market is under some short term pressure over fears of a new strain of COVID-19, which of course we hope can be kept in check to maintain our relatively stable number of…

Oxford Nanopore Technologies (ONT) is a DNA/RNA sequencing company.

Barclays has been in the news recently with the resignation of Jes Staley.

L’Oréal is a European beauty conglomerate that owns some of the best known beauty brands in the world (e.g. Lancome, Garnier, La Roche-Posay).

UBS takes about 50% of its revenues from Wealth Management.

James Godrich explains why he thinks that a patient approach can lead to short term drawdowns but remains the right strategy for long term returns.

We sponsor Dogs for Good, a charity transforming the lives of disabled people in the UK.

Brian Tora provides his insight how the recent social unrest, US renominations and Christmas will impact markets.

Brian Tora takes a look back at the last couple of weeks. Providing his insight into the PMI, the Autumn Budget and nuclear energy.

Whilst the interest rate tune might be changing, James Godrich suggests it is still inflation expectations that provides the greater risk for equity markets.